Eastern Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Eastern Bank's XBI Position: Q3 2026 in Review
Eastern Bank held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2026 at 228 shares worth $36K. The position accounts for ﹤0.01% of the portfolio, ranked #689.
Eastern Bank first reported a position in XBI in Q4 2018 and has held it in 26 quarters since. The position peaked at $30.5M in Q4 2020. 964 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Eastern Bank held 228 shares of State Street SPDR S&P Biotech ETF worth $36K as of Q3 2026.
- Eastern Bank left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2026.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of Eastern Bank's portfolio in Q3 2026, its #689 holding.
- Eastern Bank first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and has held it in 26 quarters since.
- Eastern Bank's State Street SPDR S&P Biotech ETF position peaked at $30.5M in Q4 2020.
- 964 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.